Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
hsa_circ_0067557 is a circular RNA (circRNA) derived from the RBP1 (Retinol Binding Protein 1) gene, located on chromosome 3 (PeerJ). It functions primarily as a non-coding regulatory molecule, often acting as a molecular sponge for microRNAs (miRNAs) or interacting with RNA-binding proteins to modulate gene expression (NIH). In colorectal cancer (CRC), hsa_circ_0067557 is significantly enriched in exosomes secreted by cancer-associated fibroblasts (CAFs) (MDPI). These CAF-derived exosomes transfer the circRNA to CRC cells, where it promotes malignant phenotypes such as increased proliferation, migration, invasion, and resistance to chemotherapeutic agents like 5-fluorouracil (5-FU) by upregulating the oncogenes Lin28A and Lin28B (NIH). Beyond its role in oncology, hsa_circ_0067557 has been implicated in the pathogenesis of preeclampsia, where it is predicted to function within a competing endogenous RNA (ceRNA) network involving miR-1248 and the GNB5 gene to influence the PI3K-Akt signaling pathway (Taylor & Francis). It is also found to be upregulated in gastric cancer-derived mesenchymal stem cells, suggesting a broader role in the tumor microenvironment (Spandidos Publications). Due to its stability in biofluids and its critical role in tumor progression and pregnancy-related disorders, hsa_circ_0067557 is considered a promising biomarker and a potential therapeutic target for RNA-based interventions (NIH).
Competitive endogenous RNA (ceRNA) activity and molecular sponging of microRNAs to modulate downstream gene expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on hsa_circ_0067557 (circ_0067557).